Search

Guillaume O Adelmant

age ~56

from Cambridge, MA

Also known as:
  • Guilla Adelmant
  • Adelmant Guillaume
  • Guillaume T
Phone and address:
118 Inman St, Cambridge, MA 02139
6179455670

Guillaume Adelmant Phones & Addresses

  • 118 Inman St, Cambridge, MA 02139 • 6179455670
  • 105 Pleasant St, Cambridge, MA 02139
  • 31 Dimick St, Somerville, MA 02143 • 6176298709

Us Patents

  • Pgc-1, A Novel Brown Fat Ppargamma Coactivator

    view source
  • US Patent:
    6525178, Feb 25, 2003
  • Filed:
    Jul 5, 2001
  • Appl. No.:
    09/900236
  • Inventors:
    Bruce M. Spiegelman - Waban MA
    Pere Puigserver - Brookline MA
    Zhidan Wu - Boston MA
    Guillaume Adelmant - Boston MA
  • Assignee:
    Dana-Farber Cancer Institute - Boston MA
  • International Classification:
    A61K 3800
  • US Classification:
    530350, 530324, 530326, 530328
  • Abstract:
    The invention provides isolated nucleic acids molecules, designated PGC-1 nucleic acid molecules, which encode proteins which can modulate various adipocyte-associated activities including, for example, thermogenesis in adipocytes, e. g. , brown adipocytes, and adipogenesis. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins, antigenic peptides and anti-PGC-1 antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
  • Pgc-1, A Novel Brown Fat Pparγ Coactivator

    view source
  • US Patent:
    6872391, Mar 29, 2005
  • Filed:
    Sep 27, 2002
  • Appl. No.:
    10/256889
  • Inventors:
    Bruce M. Spiegelman - Waban MA, US
    Pere Puigserver - Brookline MA, US
    Zhidan Wu - Boston MA, US
    Guillaume Adelmant - Boston MA, US
  • Assignee:
    Dana-Farber Cancer Institute - Boston MA
  • International Classification:
    A61K039/395
  • US Classification:
    4241301, 435 71, 435 911, 435326, 435810, 5303881, 530403, 436501, 536 231
  • Abstract:
    The invention provides isolated nucleic acids molecules, designated PGC-1 nucleic acid molecules, which encode proteins which can modulate various adipocyte-associated activities including, for example, thermogenesis in adipocytes, e. g. , brown adipocytes, and adipogenesis. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins, antigenic peptides and anti-PGC-1 antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
  • Pcg-1, A Novel Brown Fat Pparγ Coactivator

    view source
  • US Patent:
    6908987, Jun 21, 2005
  • Filed:
    May 16, 2003
  • Appl. No.:
    10/439799
  • Inventors:
    Bruce M. Spiegelman - Waban MA, US
    Pere Puigserver - Brookline MA, US
    Zhidan Wu - Boston MA, US
    Guillaume Adelmant - Boston MA, US
  • Assignee:
    Dana-Farber Cancer Institute, Inc. - Boston MA
  • International Classification:
    A61K038/00
  • US Classification:
    530350, 530324, 530326, 530328
  • Abstract:
    The invention provides isolated nucleic acids molecules, designated PGC-1 nucleic acid molecules, which encode proteins which can modulate various adipocyte-associated activities including, for example, thermogenesis in adipocytes, e. g. , brown adipocytes, and adipogenesis. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins, antigenic peptides and anti-PGC-1 antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
  • Pgc-1 Isoforms And Uses Therefor

    view source
  • US Patent:
    7250283, Jul 31, 2007
  • Filed:
    Jul 3, 2002
  • Appl. No.:
    10/482094
  • Inventors:
    Bruce M. Spiegelman - Waban MA, US
    Guillaume Adelmant - Boston MA, US
    Pere Puigserver - Brookline MA, US
  • Assignee:
    Dana-Farber Cancer Institute - Boston MA
  • International Classification:
    C12N 1/20
    C12N 9/02
    C12N 15/00
    C07H 21/04
  • US Classification:
    4352523, 435189, 4353201, 536 231, 536 232
  • Abstract:
    The invention provides isolated nucleic acid molecules, designated PGC-1and PGC-1nucleic acid molecules, which encode novel isoforms of PGC-1 family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins, antigenic peptides and anti-PGC-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
  • Novel Pgc-1 Isoforms And Uses Therefor

    view source
  • US Patent:
    20090098569, Apr 16, 2009
  • Filed:
    Jun 20, 2007
  • Appl. No.:
    11/765855
  • Inventors:
    Bruce M. Spiegelman - Waban MA, US
    Guillaume Adelmant - Boston MA, US
    Pere Puigserver - Brookline MA, US
  • Assignee:
    Dana-Farber Cancer Institute, Inc. - Boston MA
  • International Classification:
    G01N 33/53
    G01N 33/566
  • US Classification:
    435 71, 436501
  • Abstract:
    The invention provides isolated nucleic acid molecules, designated PGC-1b and PGC-1c nucleic acid molecules, which encode novel isoforms of PGC-1 family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins, antigenic peptides and anti-PGC-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
  • Pgc-1, A Novel Brown Fat Ppar Coactivator

    view source
  • US Patent:
    6426411, Jul 30, 2002
  • Filed:
    Dec 1, 1998
  • Appl. No.:
    09/203453
  • Inventors:
    Bruce M. Spiegelman - Waban MA
    Pere Puigserver - Brookline MA
    Zhidan Wu - Boston MA
    Guillaume Adelmant - Boston MA
  • Assignee:
    Dana-Farber Cancer Institute - Boston MA
  • International Classification:
    C07H 2104
  • US Classification:
    536 235, 536 234, 435 691, 4352523
  • Abstract:
    The invention provides isolated nucleic acids molecules, designated PGC-1 nucleic acid molecules, which encode proteins which can modulate various adipocyte-associated activities including, for example, thermogenesis in adipocytes, e. g. , brown adipocytes, and adipogenesis. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing PGC-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a PGC-1 gene has been introduced or disrupted. The invention still further provides isolated PGC-1 proteins, fusion proteins, antigenic peptides and anti-PGC-1 antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.
  • Reagents And Methods For Analysis Of Proteins And Metabolites Targeted By Covalent Probes

    view source
  • US Patent:
    20210072254, Mar 11, 2021
  • Filed:
    Oct 26, 2020
  • Appl. No.:
    17/080373
  • Inventors:
    - Boston MA, US
    Scott B Ficarro - Melrose MA, US
    Guillaume Adelmant - Cambridge MA, US
  • International Classification:
    G01N 33/68
    C07C 225/14
    C07C 233/33
    C07C 255/60
    C07C 321/04
    C07C 321/14
    C07D 209/34
    C07D 211/70
    C07D 219/04
    C07D 233/88
    C07D 241/04
    C07D 249/12
    C07D 265/30
    C07D 265/34
    C07D 265/36
    C07D 295/185
    C07D 307/54
    C07D 401/04
    C07D 401/12
    C07D 401/14
    C07D 403/04
    C07D 403/12
    C07D 471/04
    C07D 487/04
    C07D 498/06
  • Abstract:
    The present application relates to mass spectrometry methods for use in identifying proteins or other biomolecules which are bound irreversibly by test compounds.
  • Reagents And Methods For Analysis Of Proteins And Metabolites Targeted By Covalent Probes

    view source
  • US Patent:
    20190346454, Nov 14, 2019
  • Filed:
    Nov 28, 2017
  • Appl. No.:
    16/461486
  • Inventors:
    - Boston MA, US
    Scott B Ficarro - Melrose MA, US
    Guillaume Adelmant - Cambridge MA, US
  • International Classification:
    G01N 33/68
    C07D 295/185
    C07D 265/30
    C07D 265/34
    C07D 265/36
    C07D 498/06
    C07C 255/60
    C07C 321/14
    C07D 209/34
    C07D 241/04
    C07D 307/54
    C07D 233/88
    C07C 321/04
    C07D 401/04
    C07C 233/33
    C07C 225/14
    C07D 403/04
    C07D 401/14
    C07D 471/04
    C07D 487/04
    C07D 211/70
    C07D 401/12
    C07D 403/12
    C07D 249/12
    C07D 219/04
  • Abstract:
    The present application relates to mass spectrometry methods for use in identifying proteins or other biomolecules which are bound irreversibly by test compounds.

Get Report for Guillaume O Adelmant from Cambridge, MA, age ~56
Control profile